Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: Consequences for lipid accumulation in human monocyte-derived macrophages

Atherosclerosis

Volumn 155, Issue 1, 2001, Pages 251-260

  Milosavljevic, Dragana ^a   Griglio, Sabine ^a   Le Naour, Gilles ^a   Chapman, M John ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Macrophage foam cell; Particle size; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN B; FENOFIBRATE; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CAUCASIAN; CELL INCLUSION; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID STORAGE; MACROPHAGE; MALE; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTILIPEMIC AGENTS; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, VLDL; MACROPHAGES; MALE; MIDDLE AGED; PARTICLE SIZE; PROCETOFEN; TRIGLYCERIDES;

EID: 0035109541     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00634-1     Document Type: Article

References (41)

1. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial
2. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Cellular aspects
3. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reduced the production of apoB-containing lipoproteins: Implications for the pathophysiology of apoB production
4. Kinetic bases of the primary hyperlipidemias: Studies of apolipoprotein B turnover in genetically defined subjects
5. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in man: Normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
6. Lipoprotein heterogeneity and apolipoprotein B metabolism
7. Heterogeneity of apolipoprotein B-100-containing lipoproteins: What we have learnt from kinetic studies
8. Mechanism of action of fibrates on lipid and lipoprotein metabolism
9. Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia
10. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching
11. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
12. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins
13. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation
14. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL
15. Cholesterol accumulation in J774 macrophages induced by triglyceride- rich lipoproteins. Comparison of very low-density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias
16. Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans
17. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms
18. Effects of two different fibric derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinemia
19. Enzymatic determination of total serum cholesterol
20. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
21. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum
22. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo
23. Apolipoprotein E phenotyping with a single gel method: Application to the study of informative matings
24. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: Relationship between apolipoprotein B kinetics and plasma lipoproteins
25. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
26. Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages
27. A simple method for the isolation and purification of total lipides from animal tissues
28. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia
29. Micronized fenofibrate
30. Large variations in human foam cell formation in individuals: A fully autologous in vitro assay based on the quantitative analysis of cellular neutral lipids
31. Triglyceride-rich lipoproteins and progression of atherosclerosis
32. The effects of fibrates on lipoprotein and hemostatic coronary risk factors
33. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins
34. Apoliporotein E expression by human-monocyte-derived macrophages
35. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase
36. Apolipoprotein E and lipoprotein lipase secreted from human monocyte- derived macrophages modulate very low density lipoprotein uptake
37. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state-A key role for lysophosphatidylcholine
38. Perturbation of developmental gene expression in rat liver by fibric acid derivatives: Lipoprotein lipase and alpha fetoprotein as models
39. Fibrates downregulate apolipoprotein C-III expression independent of aduction of peroxisomal acyl coenzyme A oxydase
40. Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase
41. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia